Results 211 to 220 of about 2,590,210 (272)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review

Diseases of the Colon & Rectum, 2021
BACKGROUND: Combined treatment modality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is emerging as an alternative option for colorectal peritoneal metastases, but there is ambiguity regarding patient selection, treatment ...
Manas Parikh, Paul Johnson, J. Romanes, H. Freitag, M. Spring, N. Garcia-Henriquez, J. Monson   +6 more
semanticscholar   +1 more source

Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25‐year experience

Journal of Surgical Oncology, 2021
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is predominantly performed and studied in academic centers. While developing CRS/HIPEC programs in nonacademic hospitals can increase accessibility, its safety and ...
A. Nikiforchin, V. Gushchin, M. King, E. Baron, C. Nieroda, M. Sittig, A. Sardi   +6 more
semanticscholar   +1 more source

Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis

Diseases of the Colon & Rectum, 2021
Supplemental Digital Content is available in the text. BACKGROUND: Synchronous liver resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases have traditionally been contraindicated ...
M. Flood, Atandrila Das, Mikael L Soucisse, Joseph C. H. Kong, R. Ramsay, M. Michael, B. Loveday, S. Warrier, A. Heriot   +8 more
semanticscholar   +1 more source

Learning trauma surgery through cytoreductive surgery

Injury, 2023
Regarding war surgery (WS), the initial and continuing education of French military gastrointestinal surgeons (FMGIS) is considered flawed and inappropriate. This results from the low incidence of gastrointestinal (GI) trauma, its predominantly non-surgical management, and a daily surgical practice that strongly differs from WS.
Xavier Giudicelli, Olivier Aoun, Amaury Perchoc, Victor Laville, Mathieu Boutonnet, Anne de Carbonnières, Anne Cécile Ezanno, Brice Malgras   +7 more
openaire   +2 more sources

Cytoreductive Surgery for Melanoma

Surgical Oncology Clinics of North America, 2007
Cytoreductive surgery represents a therapeutic attempt to improve patient outcomes by reducing overall tumor burden to render postsurgical therapy effective or at least increase its effectiveness. The intent of cytoreduction differs from palliative or curative-intent surgery for oligometastatic melanoma.
James M, McLoughlin, Jonathan S, Zager, Vernon K, Sondak   +2 more
openaire   +2 more sources

Cytoreductive surgery

2010
Jason Wright, Thomas Herzog, Nadeem Abu-Rustum   +2 more
  +7 more sources

Cytoreductive surgery for hepatocellular carcinoma

Surgical Oncology, 1994
A prospective study was conducted on 26 patients for cytoreductive surgery of inoperable hepatocellular carcinoma. These patients underwent cytoreduction with liver resection, cryosurgery, microwave tissue coagulation and/or absolute alcohol injection. In-hospital mortality was 7.7%. The symptomatic relief and quality of survival were excellent.
W Y, Lau, T W, Leung, K L, Leung, S, Ho, N, Leung, M, Chan, J, Lin, A K, Li   +7 more
openaire   +2 more sources

Advanced cytoreductive surgery: American perspective

Gynecologic Oncology, 2009
Over the past 3 to 4 decades a special knowledge and understanding of the pathophysiology and behavior of gynecologic peritoneal surface malignancies has led to a significant improvement of the relevant treatment modalities, mirroring advances in chemotherapy approaches and improved knowledge of tumor biology.
Oliver, Zivanovic, Amadeo, Aldini, Jay W, Carlson, Dennis S, Chi   +3 more
openaire   +2 more sources

CYTOREDUCTIVE SURGERY FOR OVARIAN CANCER

Surgical Clinics of North America, 2001
Cytoreductive surgery is a crucial component of the management of cancer of the ovary. Surgical cytoreduction of ovarian cancer volume has been associated with an increase in survival in all settings in which it has been studied. This association seems strongest, and the benefits of aggressive surgery are generally greatest, in patients with ...
T C, Randall, S C, Rubin
openaire   +2 more sources

A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2.

, 2020
6001Background: In China, secondary cytoreductive surgery (SCR) has been standard of care in some high volume cancer centers for ovarian cancer (OC) and most pts prefer surgery over the past two de...
R. Zang, Jianqing Zhu, Tingyan Shi, Jihong Liu, D. Tu, S. Yin, R. Jiang, Ping Zhang, Huixun Jia, Yuting Luan, Yuqin Zhang, Xiaojun Chen, Xiao Huang, W. Tian, Wen Gao, Yanling Feng, Huijuan Yang, Xi Cheng, Yulang Cai   +18 more
semanticscholar   +1 more source